Chalet Hotels

Chalet Hotels is pursuing long-term growth through mixed-use projects and residential revenue generation. The company has a development pipeline of approximately 1,200 rooms and 0.9 million square feet of commercial space. EBITDA margins are remaining steady as the company expands into new areas and focuses on green infrastructure leadership.

Chalet Hotels Limited reported consolidated revenue of ₹9,083 million for Q1 FY26, representing 146% year-over-year growth. EBITDA increased 150% to ₹3,711 million with a margin of 40.9%. The hospitality business generated ₹3,856 million in revenue (18% growth) with EBITDA of ₹1,608 million (20% growth). The annuity business saw significant growth with revenue of ₹732 million (106% increase) and EBITDA of ₹608 million (130% increase). The company commenced revenue recognition from its residential project, contributing ₹4,391 million in revenue and ₹1,628 million in EBITDA. The company handed over 95 residential units at The Vivarea, Koramangala, Bengaluru. Hospitality operations showed mixed performance with average daily rates increasing 17% to ₹12,207 but occupancy declining 4.4 percentage points to 66%. The company added 121 rooms at Bengaluru Marriott Hotel Whitefield and 44 rooms at The Dukes Retreat. Net profit for the quarter was ₹2,031 million compared to ₹606 million in the previous year. The company maintained its expansion pipeline with projects under construction including Taj at Delhi International Airport and CIGNUS Powai Tower II.

Chalet Hotels Limited reported robust quarterly results for the period ended June 30, 2025, with consolidated revenue from operations reaching ₹8,945.51 million and profit for the period at ₹2,031.28 million. The company's EBITDA stood at ₹3,710.65 million. During the quarter, the company recognized ₹4,391.17 million revenue from its residential project in Bengaluru. The Board approved the appointment of Mr. Shwetank Singh as Managing Director & CEO Designate, effective February 1, 2026, following Dr. Sanjay Sethi's planned retirement. Dr. Sethi will continue as a Non-Executive, Non-Independent Director from February 1, 2026. The company also repaid ₹400 million of Non-Cumulative Non-Convertible Redeemable Preference Shares during the quarter, reducing the outstanding amount to ₹1,600 million.